X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ORMP

Closed

Oramed Pharmaceuticals Inc

2.1
-0.2 (-8.89%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.25
Day's Range: 2.105 - 2.2
Send
When Written:
 
2.17
Oramed Pharmaceuticals Inc. is a biopharmaceutical company that specializes in the development of oral delivery solutions for drugs that are typically administered by injection. The company is based in Jerusalem, Israel, and was founded in 2006 by Dr. Miriam Kidron and Nadav Kidron.

Oramed's lead product candidate is ORMD-0801, an oral insulin capsule for the treatment of diabetes. The company has completed several clinical trials for ORMD-0801 and is currently conducting a Phase III trial.

In addition to ORMD-0801, Oramed is also developing oral delivery solutions for other drugs, including GLP-1 agonists for the treatment of diabetes and other metabolic disorders, and oral delivery solutions for vaccines.

Oramed has partnerships with several pharmaceutical companies, including Hefei Tianhui Incubator of Technologies Co. Ltd. in China and Premas Biotech in India.

Oramed is publicly traded on the NASDAQ stock exchange under the ticker symbol ORMP.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X